226 related articles for article (PubMed ID: 22691536)
21. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
22. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.
Sartim AG; Guimarães FS; Joca SR
Behav Brain Res; 2016 Apr; 303():218-27. PubMed ID: 26801828
[TBL] [Abstract][Full Text] [Related]
23. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
Borsani E; Labanca M; Bianchi R; Rodella LF
Brain Res; 2007 Jun; 1152():87-94. PubMed ID: 17459353
[TBL] [Abstract][Full Text] [Related]
24. Interactions between the nitrergic and the endocannabinoid system in rats exposed to the elevated T-maze.
Batista LA; de Araújo Moreira F; Aguiar DC
Acta Neuropsychiatr; 2021 Aug; 33(4):206-210. PubMed ID: 33818338
[TBL] [Abstract][Full Text] [Related]
25. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.
Roohbakhsh A; Keshavarz S; Hasanein P; Rezvani ME; Moghaddam AH
Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):333-8. PubMed ID: 19614892
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
[TBL] [Abstract][Full Text] [Related]
27. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus.
Santos CJ; Stern CA; Bertoglio LJ
Behav Pharmacol; 2008 Jul; 19(4):357-60. PubMed ID: 18622185
[TBL] [Abstract][Full Text] [Related]
28. Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats.
Pardo-García TR; Yusif-Rodriguez N; Yudowski G; Maldonado-Vlaar CS
Neurosci Lett; 2020 Jul; 732():135023. PubMed ID: 32422166
[TBL] [Abstract][Full Text] [Related]
29. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
Lisboa SF; Guimarães FS
Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
[TBL] [Abstract][Full Text] [Related]
30. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test.
Lisboa SF; Resstel LB; Aguiar DC; Guimarães FS
Eur J Pharmacol; 2008 Sep; 593(1-3):73-8. PubMed ID: 18691568
[TBL] [Abstract][Full Text] [Related]
31. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats.
Bitencourt RM; Pamplona FA; Takahashi RN
Eur Neuropsychopharmacol; 2008 Dec; 18(12):849-59. PubMed ID: 18706790
[TBL] [Abstract][Full Text] [Related]
32. A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats.
Kirkedal C; Wegener G; Moreira F; Joca SRL; Liebenberg N
Acta Neuropsychiatr; 2017 Dec; 29(6):324-329. PubMed ID: 27938441
[TBL] [Abstract][Full Text] [Related]
33. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.
Rubino T; Realini N; Castiglioni C; Guidali C; Viganó D; Marras E; Petrosino S; Perletti G; Maccarrone M; Di Marzo V; Parolaro D
Cereb Cortex; 2008 Jun; 18(6):1292-301. PubMed ID: 17921459
[TBL] [Abstract][Full Text] [Related]
34. Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor.
Freitas RL; Salgado-Rohner CJ; Hallak JE; Crippa JA; Coimbra NC
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1781-98. PubMed ID: 23521775
[TBL] [Abstract][Full Text] [Related]
35. Sacred Maya incense, copal (Protium copal - Burseraceae), has antianxiety effects in animal models.
Merali Z; Cayer C; Kent P; Liu R; Cal V; Harris CS; Arnason JT
J Ethnopharmacol; 2018 Apr; 216():63-70. PubMed ID: 29414121
[TBL] [Abstract][Full Text] [Related]
36. Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze.
Gobira PH; Aguiar DC; Moreira FA
Pharmacol Biochem Behav; 2013 Sep; 110():33-9. PubMed ID: 23711591
[TBL] [Abstract][Full Text] [Related]
37. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
38. Effects of CB1 receptor agonism and antagonism on behavioral fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats.
Simone JJ; Malivoire BL; McCormick CM
Neuroscience; 2015 Oct; 306():123-37. PubMed ID: 26311003
[TBL] [Abstract][Full Text] [Related]
39. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray.
Almeida-Santos AF; Gobira PH; Rosa LC; Guimaraes FS; Moreira FA; Aguiar DC
Behav Brain Res; 2013 Sep; 252():10-7. PubMed ID: 23714073
[TBL] [Abstract][Full Text] [Related]
40. Pre-training anandamide infusion within the basolateral amygdala impairs plus-maze discriminative avoidance task in rats.
Munguba H; Cabral A; Leão AH; Barbosa FF; Izídio GS; Ribeiro AM; Silva RH
Neurobiol Learn Mem; 2011 May; 95(4):527-33. PubMed ID: 21440651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
